What is the current valuation of the ultrasound gastroscopes market in India as of 2024?

The overall market valuation was $45.02 Million in 2024. Read More

What is the projected market valuation for ultrasound gastroscopes in India by 2035?

The projected valuation for 2035 is $106.92 Million. Read More

What is the expected CAGR for the ultrasound gastroscopes market in India during the forecast period 2025 - 2035?

The expected CAGR for the market during this period is 8.18%. Read More

Which product type segment shows the highest valuation in the ultrasound gastroscopes market?

The Linear Array Ultrasound Gastroscope segment shows a valuation range of $15.0 to $35.0 Million. Read More

What are the key applications driving the ultrasound gastroscopes market in India?

Key applications include Lower GI Oncology, with a valuation range of $15.0 to $30.0 Million. Read More

Which end-user segment holds the largest market share in the ultrasound gastroscopes market?

The Hospitals and Clinics segment holds a valuation range of $18.01 to $42.0 Million. Read More

Who are the leading players in the ultrasound gastroscopes market in India?

Key players include Olympus Corporation, Fujifilm Holdings Corporation, and Medtronic plc. Read More

What is the valuation range for the Endoscopic Ultrasound Needle product type?

The valuation range for the Endoscopic Ultrasound Needle is $12.0 to $30.0 Million. Read More

How does the market for Upper Endoscopic Ultrasound (EUS) compare to Lower Endoscopic Ultrasound (EUS)?

Upper EUS has a valuation range of $15.0 to $35.0 Million, while Lower EUS ranges from $10.0 to $25.0 Million. Read More

What is the valuation range for the Others category in the By Application segment?

The Others category in the By Application segment has a valuation range of $7.02 to $19.92 Million. Read More

India Ultrasound Gastroscopes Market

ID: MRFR/HC/52356-HCR

200 Pages

Vikita Thakur

Last Updated: April 06, 2026

India Ultrasound Gastroscopes Market Research Report: By Product Type (Optic Ultrasound Gastroscopes, Others), By Application (Oncology, Others), By Procedure (Upper Endoscopic Ultrasound, Others), andBy End-user (Hospitals and Clinics, Others) - Growth & Industry Forecast 2025 To 2035

India Ultrasound Gastroscopes Market Infographic

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Pharmaceutical, BY Product Type (USD Million)
  1. 4.1.1 Optic Ultrasound Gastroscope
  2. 4.1.2 Linear Array Ultrasound Gastroscope
  3. 4.1.3 Endoscopic Ultrasound Needle
  4. 4.1.4 Others
2. 4.2 Pharmaceutical, BY Application (USD Million)
  1. 4.2.1 Oncology
  2. 4.2.2 Upper GI Oncology
  3. 4.2.3 Lower GI Oncology
  4. 4.2.4 Pancreatic Conditions
  5. 4.2.5 Others
3. 4.3 Pharmaceutical, BY Procedure (USD Million)
  1. 4.3.1 Upper Endoscopic Ultrasound (EUS)
  2. 4.3.2 Lower Endoscopic Ultrasound (EUS)
  3. 4.3.3 Endoscopic Ultrasound-Guided Fine-Needle Aspiration
  4. 4.3.4 Others
4. 4.4 Pharmaceutical, BY End-User (USD Million)
  1. 4.4.1 Hospitals and Clinics
  2. 4.4.2 Ambulatory Surgical Centers
  3. 4.4.3 Others
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Pharmaceutical
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Olympus Corporation (JP)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Fujifilm Holdings Corporation (JP)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Medtronic plc (IE)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Boston Scientific Corporation (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Pentax Medical (JP)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Conmed Corporation (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Hoya Corporation (JP)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Stryker Corporation (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 INDIA MARKET ANALYSIS BY PRODUCT TYPE
3. 6.3 INDIA MARKET ANALYSIS BY APPLICATION
4. 6.4 INDIA MARKET ANALYSIS BY PROCEDURE
5. 6.5 INDIA MARKET ANALYSIS BY END-USER
6. 6.6 KEY BUYING CRITERIA OF PHARMACEUTICAL
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF PHARMACEUTICAL
9. 6.9 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
10. 6.10 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
11. 6.11 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
12. 6.12 PHARMACEUTICAL, BY PRODUCT TYPE, 2024 (% SHARE)
13. 6.13 PHARMACEUTICAL, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
14. 6.14 PHARMACEUTICAL, BY APPLICATION, 2024 (% SHARE)
15. 6.15 PHARMACEUTICAL, BY APPLICATION, 2024 TO 2035 (USD Million)
16. 6.16 PHARMACEUTICAL, BY PROCEDURE, 2024 (% SHARE)
17. 6.17 PHARMACEUTICAL, BY PROCEDURE, 2024 TO 2035 (USD Million)
18. 6.18 PHARMACEUTICAL, BY END-USER, 2024 (% SHARE)
19. 6.19 PHARMACEUTICAL, BY END-USER, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY PRODUCT TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY APPLICATION, 2025-2035 (USD Million)
  3. 7.2.3 BY PROCEDURE, 2025-2035 (USD Million)
  4. 7.2.4 BY END-USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

India Pharmaceutical Market Segmentation

Pharmaceutical By Product Type (USD Million, 2025-2035)

Optic Ultrasound Gastroscope
Linear Array Ultrasound Gastroscope
Endoscopic Ultrasound Needle
Others

Pharmaceutical By Application (USD Million, 2025-2035)

Oncology
Upper GI Oncology
Lower GI Oncology
Pancreatic Conditions
Others

Pharmaceutical By Procedure (USD Million, 2025-2035)

Upper Endoscopic Ultrasound (EUS)
Lower Endoscopic Ultrasound (EUS)
Endoscopic Ultrasound-Guided Fine-Needle Aspiration
Others

Pharmaceutical By End-User (USD Million, 2025-2035)

Hospitals and Clinics
Ambulatory Surgical Centers
Others

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓